• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on gene therapy using non-viral vector for joint disease

Research Project

Project/Area Number 11470314
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

KUBO Toshikazu  Kyoto Prefectural University of Medicine, the medical department, Associate Professor, 医学部, 助教授 (20178031)

Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥14,700,000 (Direct Cost: ¥14,700,000)
Fiscal Year 2000: ¥6,700,000 (Direct Cost: ¥6,700,000)
Fiscal Year 1999: ¥8,000,000 (Direct Cost: ¥8,000,000)
Keywordsgene therapy / non-viral vector / chondrocyte / HCS-2 / 8 / joint disease / drug delivery system / polymer / EBV
Research Abstract

Usefulness of three types of cationic polymer, i.e., degraded polyamidoamine (PAMAM) dendrimer (SuperFect Transfection Reagent), linear polyethylenimine (PEI) (ExGen 500) and branched PEI in gene delivery into chondrocytes was comparatively examined. A plasmid vector containing the E.coli LacZ (pSES.β) was combined with one of the three cationic polymers at various molar ratios and the resultant complex (polyplex) was used to transduce a human chondrocyte-like cell line, HCS-2/8. Gene expression was evaluated by the O-Nitrophenyl β-D-Galactopyranoside (ONPG) assay and X-gal staining. The ONPG assay showed that the highest delivery rate was achieved when 2 μg of pSES.β was combined with either 21 μg of dendrimer, 1.7 μg of linear PEI, or 2.0 μg of branched PEI.At the same DNA/polymer ratios, the proportions of X-gal-staining cells were also the highest (31, 30, and 8%, respectively). LacZ expression reached the highest level 3days after the dendrimer-mediated transduction, gradually declined and returned to the background level on day 14. Possible cytotoxicity was examined by trypan blue staining and phase contrast microscopic observations. Neither cytotoxicity nor morphological change was induced at the optimal dose of each polymer. The cationic polymers, particularly the degraded dendrimer and linear PEI, would be a useful non-viral vector for gene delivery to the cells in chondrocyte lineage.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] S.Ohashi, et al.: "Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells."Journal of Orthopaedic Science. 6. 75-81 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 久保俊一 他: "関節疾患に対する非ウイルスベクターを用いた遺伝子導入法."整形外科. 51. 839-845 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] S.Ohashi: "Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 Cells."Journal of Orthopaedic Science. 6. 75-81 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] S.Ohashi, et al.: "Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells."Journal of Orthopaedic Science. 6. 75-81 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 久保俊一 他: "関節疾患に対する非ウイルスベクターを用いた遺伝子導入法."整形外科. 51. 839-845 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi